Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavio Forrer

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2011
Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomasDamian Wild, Emanuel Christ, Martyn E Caplin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 1, 2023
Early response monitoring during [<sup>177</sup>Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry studyMoritz C Neubauer, Guillaume P Nicolas, Andreas Bauman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 28, 2009
Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotateFlavio Forrer, Eric P Krenning, Peter P Kooij, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging studyEmanuel Christ, Damian Wild, Susanne Ederer, et al.
Aging Cell|November 3, 2009
Short-term dietary restriction and fasting precondition against ischemia reperfusion injury in miceJames R Mitchell, Mariëlle Verweij, Karl Brand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2009
Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patientsZoran Erlic, Lisa Rybicki, Mariola Peczkowska, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 24, 2019
EANM procedure guidelines for radionuclide therapy with <sup>177</sup>Lu-labelled PSMA-ligands (<sup>177</sup>Lu-PSMA-RLT)Clemens Kratochwil, Wolfgang Peter Fendler, Matthias Eiber, et al.
JAMA|October 27, 2005
Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC geneFrancesca Schiavi, Carsten C Boedeker, Birke Bausch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 29, 2023
Joint EANM/SNMMI procedure guideline for the use of <sup>177</sup>Lu-labeled PSMA-targeted radioligand-therapy (<sup>177</sup>Lu-PSMA-RLT)Clemens Kratochwil, Wolfgang P Fendler, Matthias Eiber, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2011
Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomasDamian Wild, Emanuel Christ, Martyn E Caplin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 1, 2023
Early response monitoring during [<sup>177</sup>Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry studyMoritz C Neubauer, Guillaume P Nicolas, Andreas Bauman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 28, 2009
Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotateFlavio Forrer, Eric P Krenning, Peter P Kooij, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging studyEmanuel Christ, Damian Wild, Susanne Ederer, et al.
Aging Cell|November 3, 2009
Short-term dietary restriction and fasting precondition against ischemia reperfusion injury in miceJames R Mitchell, Mariëlle Verweij, Karl Brand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2009
Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patientsZoran Erlic, Lisa Rybicki, Mariola Peczkowska, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 24, 2019
EANM procedure guidelines for radionuclide therapy with <sup>177</sup>Lu-labelled PSMA-ligands (<sup>177</sup>Lu-PSMA-RLT)Clemens Kratochwil, Wolfgang Peter Fendler, Matthias Eiber, et al.
JAMA|October 27, 2005
Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC geneFrancesca Schiavi, Carsten C Boedeker, Birke Bausch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 29, 2023
Joint EANM/SNMMI procedure guideline for the use of <sup>177</sup>Lu-labeled PSMA-targeted radioligand-therapy (<sup>177</sup>Lu-PSMA-RLT)Clemens Kratochwil, Wolfgang P Fendler, Matthias Eiber, et al.
Pageof 4